Invention Grant
US08524282B2 Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
有权
生产高纯度磷脂的方法,以及高纯度鞘磷脂和通过该方法生产的脂质体型甘油磷脂
- Patent Title: Method for production of highly pure phospholipid, and highly pure sphingomyelin and plasmalogen-type glycerophospholipid produced by the method
- Patent Title (中): 生产高纯度磷脂的方法,以及高纯度鞘磷脂和通过该方法生产的脂质体型甘油磷脂
-
Application No.: US12999801Application Date: 2009-06-19
-
Publication No.: US08524282B2Publication Date: 2013-09-03
- Inventor: Yoshitaka Nadachi , Siro Mawatari
- Applicant: Yoshitaka Nadachi , Siro Mawatari
- Applicant Address: JP Tokyo JP Osaka JP Fukuoka
- Assignee: Umeda Jimusho Ltd.,Marudai Food Co., Ltd.,Boocs Medical Corporation
- Current Assignee: Umeda Jimusho Ltd.,Marudai Food Co., Ltd.,Boocs Medical Corporation
- Current Assignee Address: JP Tokyo JP Osaka JP Fukuoka
- Agency: Sughrue Mion, PLLC
- Priority: JP2008-162119 20080620
- International Application: PCT/JP2009/061666 WO 20090619
- International Announcement: WO2009/154309 WO 20091223
- Main IPC: A61K35/12
- IPC: A61K35/12 ; C07C231/00 ; A23J7/00 ; C12P7/64

Abstract:
This invention provides a process for producing a high-purity sphingomyelin and a high-purity plasmalogen-form glycerophospholipid from a biological material by simple procedures at high yields. The process comprises the steps of: (A) subjecting dried total lipids extracted from a biological material to extraction treatment with a specific mixture solution to separate an insoluble portion composed mainly of sphingomyelin and a soluble portion; (B) subjecting the insoluble portion, obtained in said Step (A), to washing treatment with a specific mixture solution to obtain crude sphingomyelin; (C) subjecting the soluble portion, obtained in said Step (A), to washing treatment with a water-soluble ketone solvent to obtain crude plasmalogen-form glycerophospholipid; (D) causing an enzyme to act on the crude sphingomyelin, obtained in said Step (B), to obtain sphingomyelin having a purity of 90% or more; and (E) causing an enzyme to act on the crude plasmalogen-form glycerophospholipid, obtained in said Step (C), to obtain plasmalogen-form glycerophospholipid having a purity of 40% or more.
Public/Granted literature
Information query